Author:
Baugh Evan H,Ke Hua,Levine Arnold J,Bonneau Richard A,Chan Chang S
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Reference22 articles.
1. Hainaut P, Pfeifer G . Somatic TP53 Mutations in the Era of Genome Sequencing. In: Lozanzo G, Levine AJ (eds). The p53 Protein, From Cell Regulation to Cancer.1st edn, Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 2016 pp 279–300.
2. Bouaoun L, Sonkin D, Ardin M, Hollstein M, Brynes G, Zaudail J et al. TP53 variations in human cancers: new lessons from the IARC database and genomics. Hum Mutat 2016; 37: 865–876.
3. Lee J-K, Wang J, Sa JK, Ladewig E, Lee H-O, Lee I-H et al. Spatiotemporal genomic architecture informs precision oncology in glioblastoma. Nat Genet 2017; 49: 594–599.
4. Joerger AC, Fersht AR. The tumor suppressor p53: from structures to drug discovery. In: Levine AJ, Lane DP (eds). The p53 Family. 1st edn, Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 2016 pp 19–38.
5. Campomenosi P, Monti P, Aprile A, Abbondandolo A, Frebourg T, Gold B et al. P53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Onocgene 2001; 20: 3573–3579.
Cited by
377 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献